Philip Petteruti
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Angiogenesis and VEGF in Cancer, PARP inhibition in cancer therapy, Cell Adhesion Molecules Research
Most-Cited Works
- → AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies(2016)154 cited
- → Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6(2018)136 cited
- → Potent and selective bivalent inhibitors of BET bromodomains(2016)134 cited
- → Discovery and Mechanistic Study of a Small Molecule Inhibitor for Motor Protein KIFC1(2013)121 cited
- → Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering(2015)62 cited
- → Shear Stress Decreases Endothelial Cell Tissue Factor Activity by Augmenting Secretion of Tissue Factor Pathway Inhibitor(2001)51 cited
- → MEDI0639: A Novel Therapeutic Antibody Targeting Dll4 Modulates Endothelial Cell Function and Angiogenesis In Vivo(2012)51 cited
- → Pharmacological Inhibition of PARP6 Triggers Multipolar Spindle Formation and Elicits Therapeutic Effects in Breast Cancer(2018)45 cited
- → Structure-Guided Design and In-Cell Target Profiling of a Cell-Active Target Engagement Probe for PARP Inhibitors(2020)28 cited
- → Identification of CCR2 and CD180 as Robust Pharmacodynamic Tumor and Blood Biomarkers for Clinical Use with BRD4/BET Inhibitors(2017)24 cited